Omega-3-acid ethyl esters (Trygg Pharma)

ω-3酸乙酯 (Trygg Pharma)

Report date: 2026/05/12 20:00:17

Base Information

Drug NameOmega-3-acid ethyl esters (Trygg Pharma)
Drug Alias NameOmega 3 acid ethyl estersOmega-3 ethyl estersOmega-3 Ethyl EstersOmtrygLovaza +[15] 
ClassificationSmall molecules
Mechanisms of ActionTriglyceride modulatorsLipid modulators
TargetsTriglycerideLipid
Therapy Area/IndicationsHypertriglyceridemiaHyperlipidemiasBlister +[9] 
Global Approved IndicationsHypertriglyceridemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2004/11/10
Country/TerritoryUnited StatesGermanyUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesTrygg
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalWaylis Therapeutics LLCUniversity Of East Anglia
Inactive CompaniesAbbott LaboratoriesAbbott Products GmbhGmpack Aps +[9] 
Active IndicationsHypertriglyceridemiaBlisterDermatitis +[4] 
Inactive IndicationsHyperlipidemiasMyocardial InfarctionCardiovascular Diseases +[5] 

Other Information

ATC CodeC10AX06
Related LinksWikipediaDrugBankKEGG